Ares Financial Consulting
BSX icon

Ares Financial Consulting’s Boston Scientific BSX Stock Holding History

Ares Financial Consulting’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.4K Sell
55
-76
-58% -$3.52K ﹤0.01% 844
2026
Q2 		$5.59K Sell
131
-309
-70% -$16.8K ﹤0.01% 688
2026
Q1 		$27.3K Hold
440
– – 0.02% 327
2025
Q4 		$42K Buy
+440
New +$43.1K 0.04% 173

Other funds holding BSX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Ares Financial Consulting's BSX Position: Q3 2026 in Review

Ares Financial Consulting reduced its Boston Scientific (BSX) stake by 58% in Q3 2026, selling an estimated $3.52K and leaving 55 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Ares Financial Consulting first reported a position in BSX in Q4 2025 and has held it in 4 quarters since. The position peaked at $42K in Q4 2025. 957 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Ares Financial Consulting held 55 shares of Boston Scientific worth $2.4K as of Q3 2026.
  • Ares Financial Consulting sold 76 Boston Scientific shares in Q3 2026, an estimated $3.52K.
  • Boston Scientific made up ﹤0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #844 holding.
  • Ares Financial Consulting first reported a position in Boston Scientific in Q4 2025 and has held it in 4 quarters since.
  • Ares Financial Consulting's Boston Scientific position peaked at $42K in Q4 2025.
  • 957 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.